Patent Assignment
Reel/Frame 052371/0687
Merger and Change of Name
Recorded: 2020-04-10
Pages: 31
Assignors
DOV PHARMACEUTICAL, INC.
Executed: 2010-07-20
DOV PHARMACEUTICAL, INC.
Executed: 2010-07-20
Assignee
EUTHYMICS BIOSCIENCE, INC.
50 BRAINTREE HILL OFFICE PARK, SUITE 301, BRAINTREE, MASSACHUSETTS, 02184
Covered Property
(1)
Novel 1-Aryl-3-Azabicyclo[3.1.0]Hexanes: Preparation And Use To Treat Neuropsychiatric Disorders
Application:
16/805,334 →
Publication:
US 2021/0023049
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Apr 10, 2020
From: SKOLNICK, PHIL; BASILE, ANTHONY; CHEN, ZHENGMING; EPSTEIN, JOSEPH W.
To: DOV PHARMACEUTICAL, INC.
Reel/Frame 052366/0773 →
Assignment of Assignor's Interest
Apr 10, 2020
From: EUTHYMICS BIOSCIENCE, INC.
To: NEUROVANCE, INC.
Reel/Frame 052373/0104 →
Assignment of Assignor's Interest
Apr 10, 2020
From: EUTHYMICS BIOSCIENCE, INC.
To: NEUROVANCE, INC.
Reel/Frame 052373/0116 →
Merger
Apr 10, 2020
From: NEUROVANCE, INC.
To: OTSUKA AMERICA PHARMACEUTICAL, INC.
Reel/Frame 052373/0131 →